Title: |
Results of a Phase II Open-Label Trial of Bortezomib in Patients with Multiple Myeloma Who Have Undergone High-Dose Melphalan Therapy Followed by Autologous Peripheral Blood Stem Cell Transplantation and Failed to Achieve a Complete Response |
Source: |
Blood
[0006-4971]
Rifkin,
Robert
yr:2008
|
|
|
|